Epic Ventures Gains $200M Fresh Capital
August 28, 2025
Epic Ventures has received $200M of fresh capital to support early-stage founders solving meaningful problems in healthcare, software, AI, and beyond. The fund is positioned as a strategic public and private initiative to back the region’s best entrepreneurs and attract collaboration between the top innovators in the world and the principal economic centers of the Intermountain West. The company will be investing locally and globally.
Recent News
- Ardelyx Presents Real-World Data at ACG 2026 Showing Reduced Healthcare Resource Utilization Following IBSRELA Initiation in Adults with IBS-C
- Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe
- Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development
- Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease
- BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients
- Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
